Skip to content

Clinical trials

Mental Disorders trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mental Disorders Country / region: Australia Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20053
20061
20081
20101
20112
20123
20141
20151
20172
20183
20191
20202
20211
20223
20232
20242
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated6
Unknown status6
Recruiting4
Active, not recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The Alfred7
AstraZeneca2
Bayside Health2
GlaxoSmithKline2
HB BioTech, LLC2
Inmune Bio, Inc.2
Pfizer2
Alkahest, Inc.1
Baker Heart and Diabetes Institute1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mental Disorders33
Brain Diseases9
Central Nervous System Diseases9
Dementia9
Nervous System Diseases9
Alzheimer Disease8
Neurocognitive Disorders7
Neurodegenerative Diseases6
Tauopathies6
Mood Disorders5

Trials

Showing 76 to 33 of 33. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.